Derangements in purine nucleotide synthesis and interconversion are associated with a number of clinical disorders. Increased puring biosynthesis leads to overproduction of uric acid, and the resultant hyperuricemia and hyperuricosuria may cause gout and/or renal calculi. Enzymatic defects in the interconversion pathway referred to as the purine nucleotide cycle have been associated with a clinical myopathy. The objective of this proposal is to define the mechanisms which control the rate of purine nucleotide synthesis and hence uric acid production and to better understanding the role of the purine nucleotide cycle in skeletal muscle function.
One specific aim i s to determine what regulates the activity of PP-ribose-P amidotransferase, amidophosphoribosyltransferase, in human cells. The following hypothesis will be tested in these studies: oxygen inactivation of amidophosphoribosyltransferase, which is an iron-sulfur, oxygen-sensitive enzyme, is the initial step leading to degradation of this protein and variability in the sensitivity of this enzyme to oxygen inactivation regulates the activity of this enzyme in the cell. Radio-immunoprecipitation studies are described to define the rate of inactivation and degradation of this enzyme under different growth conditions. The other specific aim is to determine what controls the developmental expression of the purine nucleotide cycle enzymes during myocyte differentiation, what controls flux through this cycle, and what are the physiological consequences of distruption of this cycle. Patients with inherited enzyme defects, i.e. AMP deaminase deficiency, and animal models (rats) of nucleotide cycle disorders will be evaluated for muscle performance, as well as the biochemical basis for muscle dysfunction. Myocyte cell culture models will be used to study the expression of muscle specific isozymes of the purine nucleotide cycle enzymes during differentiation. Intracellular protein turnover and in vitro translation techniques will be used to determine the basis for the increase in activity of the muscle specific isozymes of the purine nucleotide cycle enzymes during differentiation. Studies with purified nucleotide cycle enzymes and contractile proteins will determine if binding of the nucleotide cycle enzymes to contractile proteins plays a role in controlling the activity of these enzymes in the myocyte.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM012413-18
Application #
3150826
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1979-05-01
Project End
1989-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
18
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Manfredi, J P; Marquetant, R; Magid, A D et al. (1989) Binding of adenylosuccinate synthetase to contractile proteins of muscle. Am J Physiol 257:C29-35
Marquetant, R; Desai, N M; Sabina, R L et al. (1987) Evidence for sequential expression of multiple AMP deaminase isoforms during skeletal muscle development. Proc Natl Acad Sci U S A 84:2345-9
Sabina, R L; Marquetant, R; Desai, N M et al. (1987) Cloning and sequence of rat myoadenylate deaminase cDNA. Evidence for tissue-specific and developmental regulation. J Biol Chem 262:12397-400
Flanagan, W F; Holmes, E W; Sabina, R L et al. (1986) Importance of purine nucleotide cycle to energy production in skeletal muscle. Am J Physiol 251:C795-802
Marquetant, R; Manfredi, J P; Holmes, E W (1986) Binding of phosphorylase a and b to skeletal muscle thin filament proteins. Arch Biochem Biophys 245:404-10
Sabina, R L; Patterson, D; Holmes, E W (1985) 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J Biol Chem 260:6107-14